234
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Age-adjusted Charlson comorbidity index as a prognostic factor of hypopharyngeal cancer treated with chemoradiation therapy

, , , , , , , , , & show all
Pages 668-673 | Received 04 Oct 2016, Accepted 19 Nov 2016, Published online: 13 Jan 2017

References

  • Takenaka Y, Yamamoto M, Nakahara S, Yamamoto Y, Yasui T, Hanamoto A, et al. Factors associated with malnutrition in patients with head and neck cancer. Acta Otolaryngol 2014;134:1079–85.
  • Maruyama H, Yasui T, Ishikawa-Fujiwara T, Morii E, Yamamoto Y, Yoshii T, et al. Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population. Cancer Sci 2014;105:409–17.
  • Boje CR, Dalton SO, Gronborg TK, Primdahl H, Kristensen CA, Andersen E, et al. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database. Acta Oncol 2013;52:285–93.
  • Ryu CH, Roh JL, Kim SB, Lee SW, Choi SH, Nam SY, Kim SY. Risk factors for non-cancer health events in patients with head and neck squamous cell carcinoma. Ann Oncol 2013;24:1049–54.
  • Takenaka Y, Yasui T, Enomoto K, Miyabe H, Morizane N, Ashida N, et al. Risk factors associated with competing mortality among patients with head and neck cancer in Japan. Acta Otolaryngol 2016;136:325–9.
  • Liu CT, Chiu TJ, Huang TL, Chien CY, Fang FM. Impact of comorbidity on survival for locally advanced head and neck cancer patients treated by radiotherapy or radiotherapy plus chemotherapy. Chang Gung Med J 2010;33:283–91.
  • Boje CR. Impact of comorbidity on treatment outcome in head and neck squamous cell carcinoma - A systematic review. Radiother Oncol 2014;110:81–90.
  • Pignon JP, le Maitre A, Maillard E, Bourhis J, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4–14.
  • Koppie TM, Serio AM, Vickers AJ, Vora K, Dalbagni G, Donat SM, Herr HW, Bochner BH. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008;112:2384–92.
  • Inohara H, Takenaka Y, Yoshii T, Nakahara S, Yamamoto Y, Tomiyama Y, Seo Y, et al. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2015;91:934–41.
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
  • Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245–51.
  • Shen W, Sakamoto N, Yang L. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis. Ann Surg Oncol 2015;22:264–71.
  • Suidan RS, Leitao MM Jr, Zivanovic O, Gardner GJ, Long Roche KC, Sonoda Y, et al. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer. Gynecol Oncol 2015;138:246–51.
  • Wu CC, Hsu TW, Chang CM, Yu CH, Lee CC. Age-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation. Medicine (Baltimore) 2015;94:e431.
  • Yang CC, Chen PC, Hsu CW, Chan S-L, Lee C-C. Validity of the age-adjusted charlson comorbidity index on clinical outcomes for patients with nasopharyngeal cancer post radiation treatment: a 5-year nationwide cohort study. PLoS One 2015;10:e0117323.
  • Rietbergen MM, Brakenhoff RH, Bloemena E, Witte BI, Snijders PJF, Heideman DAM, et al. Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol 2013;24:2740–5.
  • Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK. Population-based study of competing mortality in head and neck cancer. J Clin Oncol 2011;29:3503–9.
  • Hanamoto A, Takenaka Y, Shimosegawa E, Ymamamoto Y, Yoshi T, Nakahara S, Hatazawa J, Inohara H. Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer. Ann Nucl Med 2013;27:880–5.
  • Adelstein DJ, Rodriguez CP. Current and emerging standards of concomitant chemoradiotherapy. Semin Oncol 2008;35:211–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.